KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Titel:
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Auteur:
Wykoff, Charles C. Garweg, Justus G. Regillo, Carl Souied, Eric Wolf, Sebastian Dhoot, Dilsher S. Agostini, Hansjuergen T. Chang, Andrew Laude, Augustinus Wachtlin, Joachim Kovacic, Lidija Wang, Lixin Wang, Ying Bouillaud, Emmanuel Brown, David M.